Abstract
Aptamers, like antibodies, have high molecular recognition specificity and selectivity. Coupled with microfluidic devices, apatamers and target-aptamer complexes can be rapidly separated while only a small sample volume is required. Trace protein detection using aptamer probes on a microchip platform was demonstrated using vascular endothelial growth factor 165 (VEGF165) and a selective aptamer probe as a model system. The fluorescently labeled aptamer was separated from the VEGF165-aptamer complex in 10 s. The equilibrium dissociation constant of the complex was determined to be 8.0 nM using frontal analysis on the microchip. Two calibration curves were constructed with a detection limit of 1.0 nM VEGF165 using pinched and gated injections. The blood plasma effects on the microchip electrophoretic separation and VEGF165-aptamer complex formation were investigated using rat blood plasma. Results demonstrate the power of microchip capillary electrophoresis in terms of assay speed, low reagent consumption and high separation efficiency. However, they also indicate the necessity of further improvements in the detection limit and/or the pretreatment of the plasma sample when measured by microchip CE.
Keywords: Microchip, Affinity probe, Capillary electrophoresis, Aptamer, Growth factor
Current Pharmaceutical Analysis
Title: Detection of VEGF165 Using an Aptamer Affinity Probe in Microchip Capillary Electrophoresis
Volume: 5 Issue: 2
Author(s): Maojun Gong, Kenneth R. Wehmeyer, H. Brian Halsall and William R. Heineman
Affiliation:
Keywords: Microchip, Affinity probe, Capillary electrophoresis, Aptamer, Growth factor
Abstract: Aptamers, like antibodies, have high molecular recognition specificity and selectivity. Coupled with microfluidic devices, apatamers and target-aptamer complexes can be rapidly separated while only a small sample volume is required. Trace protein detection using aptamer probes on a microchip platform was demonstrated using vascular endothelial growth factor 165 (VEGF165) and a selective aptamer probe as a model system. The fluorescently labeled aptamer was separated from the VEGF165-aptamer complex in 10 s. The equilibrium dissociation constant of the complex was determined to be 8.0 nM using frontal analysis on the microchip. Two calibration curves were constructed with a detection limit of 1.0 nM VEGF165 using pinched and gated injections. The blood plasma effects on the microchip electrophoretic separation and VEGF165-aptamer complex formation were investigated using rat blood plasma. Results demonstrate the power of microchip capillary electrophoresis in terms of assay speed, low reagent consumption and high separation efficiency. However, they also indicate the necessity of further improvements in the detection limit and/or the pretreatment of the plasma sample when measured by microchip CE.
Export Options
About this article
Cite this article as:
Gong Maojun, Wehmeyer R. Kenneth, Halsall Brian H. and Heineman R. William, Detection of VEGF165 Using an Aptamer Affinity Probe in Microchip Capillary Electrophoresis, Current Pharmaceutical Analysis 2009; 5 (2) . https://dx.doi.org/10.2174/157341209788172933
DOI https://dx.doi.org/10.2174/157341209788172933 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Fibroblast Growth Factor Receptor Inhibitors
Current Pharmaceutical Design Cyclin-Dependent Kinase 4/6 (Cdk4/6) Inhibitors: Perspectives in Cancer Therapy and Imaging
Mini-Reviews in Medicinal Chemistry Biomarkers in Amyotrophic Lateral Sclerosis: Is There A Neurovascular Pathway?
Current Neurovascular Research Combretastatin A-4 Analogs as Anticancer Agents
Mini-Reviews in Medicinal Chemistry B-Cell Based Gene Therapy for Inducing Tolerance
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Nanotechnology and Animal Health
Pharmaceutical Nanotechnology HDAC Inhibitor Sodium Butyrate Augments the MEF2C Enhancement of Nampt Expression under Hypoxia
Current Pharmaceutical Design Multicolor-FISH Approaches for the Characterization of Human Chromosomes in Clinical Genetics and Tumor Cytogenetics
Current Genomics Immune System Induction of Nerve Growth Factor in an Animal Model of Multiple Sclerosis: Implications in Re-Myelination and Myelin RepairATION AND MYELIN REPAIR
CNS & Neurological Disorders - Drug Targets Effects of Anticancer Drugs in Reproductive Parameters of Juvenile Male Animals and Role of Protective Agents
Anti-Cancer Agents in Medicinal Chemistry Receptor Tyrosine Kinases as Target for Anti-Cancer Therapy
Current Pharmaceutical Design T Cell Redirecting Therapies for Cancer Treatment
Current Cancer Drug Targets Recent Advances in Semisynthesis, Biosynthesis, Biological Activities,Mode of Action, and Structure-Activity Relationship of Podophyllotoxins:An Update (2008-2010)
Mini-Reviews in Medicinal Chemistry Meet Our Editorial Board Member
Recent Patents on Anti-Cancer Drug Discovery Redox Status in Periodontal and Systemic Inflammatory Conditions Including Associated Neoplasias: Antioxidants as Adjunctive Therapy?
Infectious Disorders - Drug Targets Peptidic Tumor Targeting Agents: The Road from Phage Display Peptide Selections to Clinical Applications
Current Pharmaceutical Design Combinatorial Application of Nucleic Acid-Based Agents Targeting Protein Kinases for Cancer Treatment
Current Pharmaceutical Design Curcumin and its Formulations: Potential Anti-Cancer Agents
Anti-Cancer Agents in Medicinal Chemistry Structure of Multidrug-Resistance Proteins of the ATP-Binding Cassette (ABC) Superfamily
Current Medicinal Chemistry - Anti-Cancer Agents The Epigenetics of Breast Carcinogenesis and Metastasis
Current Genomics